Y.MakriyannisA.PiomelliD
The World Anti-Doping Agency (WADA) prohibits BPC-157 use in competitive sports, classifying it as a banned substance under prohibited peptides and growth factors
Anti-VEGF injections vs angiogenic peptides Anti-VEGF mechanism: Bevacizumab (Avastin), ranibizumab (Lucentis), aflibercept (Eylea) bind VEGF preventing receptor binding
Product Attributes CAS # : 137525-51-0 Molecular Formula : C62H98N16O22 Sequence (AA) : GEPPPGKPADDAGLV Molecular Weight : 1419.5 g/mol PubChem CID : 9941957 Half-Life : ~4-6 hours Synonyms : Body Protection Compound-157, Gastric Pentadecapeptide BPC157, PL 14736, Bepecin, PL-10 Type : Synthetic research peptide (cytoprotective fragment) Research Focus : Recovery & Performance, Immunity & Inflammation Scientific References Emerging use of BPC-157 in orthopaedic sports medicine Animal | In vitro BPC-157 benefits, dosage, and side effects Observational | Animal | In vitro BPC 157: science-backed uses, benefits, dosage, and safety Observational | Animal | In vitro Pentadecapeptide BPC 157 enhances the growth hormone receptor expression Animal | In vitro Multifunctionality and possible medical application of the BPC 157 peptide Observational | Animal | In vitro BPC-157: miracle healing peptide or hidden danger
Women of color are prone to melasma, but people of any skin type can get melasma
